Answers are grounded in this paper and cite their sources.
Background: Trichomoniasis is the most common non-viral sexually transmitted disease caused by the protozoan parasite Trichomonas vaginalis. Metronidazole (MTZ), a 5-nitroimidazole derivative, is the main antitrichomonal agent of choice for the treatment of trichomoniasis. Since 1962, some cases of treatment failure with metronidazole have been reported, and the increased resistance of the parasite to MTZ has emerged as a highly problematic public health issue. This study aimed to determine the current susceptibility of isolates of T. vaginalis to metronidazole in Bushehr city.
No takes yet. Share an insight, caveat, or question.
Taherzadeh et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: